Skip to main content
AT

AEye Technologies

AEye Technologies offers an AI-powered VEEG platform that analyzes EEG signals to create 3D brain models for accurate neurological diagnoses and personalized treatment plans. This technology enables cost-effective remote monitoring, improving patient access to care while reducing the need for hospitalization.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional neurological diagnoses rely on EEG signal analysis, which can be time-consuming, require hospitalization, and may involve invasive procedures like wet electrodes. This can lead to increased costs, reduced patient comfort, and potential delays in treatment.

Solution

AEye Technologies offers an AI-powered VEEG (Video Electroencephalography) platform designed to streamline neurological diagnoses and personalize treatment plans. The platform analyzes EEG signals to construct a 3D brain model, providing real-time insights into brain activity. By leveraging AI, the solution aims to enhance the accuracy of diagnoses, facilitate remote monitoring, and reduce the need for hospitalization. The platform also supports the exploration of AI applications in managing various neurological disorders, including migraine, pain management, and depression.

Target Audience

The primary target audience includes neurologists, medical institutions, and researchers seeking to improve the accuracy, efficiency, and accessibility of neurological diagnoses and treatment.

Features

  • AI-driven analysis of EEG signals for real-time insights into brain activity
  • 3D brain model creation for enhanced visualization and understanding of neurological conditions
  • Remote monitoring capabilities, eliminating the need for hospital stays and reducing costs
  • Non-invasive procedure, improving patient comfort and experience
  • Streamlined patient care through efficient data processing and reduced specialist shortages
  • Personalized treatment plans tailored to unique brain patterns
  • Integration with leading medical institutions and neurologists for collaborative progress
This profile is AI-generated and may contain inaccuracies.